The selective approach of some campaign groups regarding the credibility of the European Food Safety Authority (EFSA) results in a “general erosion of trust” in the bodies designed to protect public health, EFSA director Bernhard Url told EURACTIV.com in an interview.
The next European Commission should enhance its collaboration with the EU’s Scientific Advisory Mechanism (SAM), which would provide bias-free consultancy and eventually adjust the Tobacco Product Directive to the reality, JTI’s Ramunas Macius said in an interview with EURACTIV.com.
Austria’s EU Presidency will focus on “strong” investment in digital health as well as on regulatory issues when it comes to access to medicines, Dr Clemens Martin Auer told EURACTIV.com in an interview. Dr Clemens Martin Auer is the president of the...
The next European Commission should focus on the bloc’s role in the global context of innovation, as China is “decisive” about creating a reliable framework for intellectual property and connecting biotech start-ups and digital companies, EFPIA’s President Stefan Oschmann told EURACTIV.com in an interview.
The use of combination vaccines can bring about better vaccine coverage and this will improve protection of the public against vaccine-preventable diseases, reduce costs for treatment of these diseases and help prevent outbreaks that would otherwise occur, Mel Kohn told EURACTIV.com.
An innovation-driven approach – ranging from vaccination to other health management solutions and appropriate biosecurity measures – will ensure more sustainable future livestock farming and protection of public health, as animal diseases do not recognise borders, Roxane Feller told EURACTIV.com.
The European Commission has learned its lesson from the glyphosate controversy and is coming forward with “bold proposals” on transparency, says Bernhard Url. The raw data of all industry-funded studies related to pesticides will be made publicly available under Commission plans, he told EURACTIV in an interview.
Public health authorities at EU and national level have started working to “occupy more of the space on social media”, as it is currently almost entirely taken up by people who are against vaccination, Dr Andrea Ammon told EURACTIV.com in an interview.
The generic industry’s request for an SPC (supplementary protection certificates) manufacturing waiver, which would allow them to produce in the EU SPC-protected drugs for other markets, does not influence or harm innovators’ rights, Marc–Alexander Mahl told EURACTIV.com in an interview. He...
The decision to raise excise taxes on alcohol “penalises” the majority of consumers who drink responsibly, while those who have issues with alcohol will be unaffected as they will keep on drinking excessively, Alexandre Ricard told EURACTIV.com in an interview.
Two out of three EU countries do not measure energy poverty but a new observatory launched on Monday (29 January) should provide member states with the information they need to address a problem that could affect more than 100 million people in Europe, says the chair of the EU's Energy Poverty Observatory.
The European Union should not create an environment more favourable to generics compared to the innovative pharmaceuticals, as it risks weakening Europe’s overall global strength in pharmaceuticals and in research, Professor Adrian Towse told EURACTIV.com in an interview.
When coming up with policy, EU officials and lawmakers have a variety of sources to call upon for scientific advice. But how useful is the information and how effective is the system in place? Julie Girling explained how she uses evidence in her day-to-day life as an MEP.
At the latest United Nations environment summit, pollution topped the agenda. The man leading the UN’s quest to clean up the planet hopes this meeting will act as the wake-up call countries need and that the fight will include the world of business.
Stricter rules on smoking, reimbursed anti-smoking programmes and smoke-free public places are among the ways to prevent chronic obstructive pulmonary disease (COPD) from being a public health crisis, says Mikaela Odemyr.
Progress has been made on tobacco products health warnings but the next round of graphic labelling should also mention the less-known chronic obstructive pulmonary disease (COPD), which happens to be the second cause of death worldwide, MEP Karin Kadenbach told EURACTIV.com.
An electronic immunisation record system, which aims to better monitor vaccination among populations, will need clear privacy rules and individuals should be the owners of their own data, Patricia Massetti told EURACTIV.com in an interview. Patricia Massetti is an associate...
“Salami-slicing” the cost of medicines, which represent almost one-fifth of health system budgets and are subject to rigorous value assessments, won’t make healthcare systems more sustainable in the future, Nathalie Moll told EURACTIV.com in an interview.
Accessibility of medicines is a sensitive issue that must not be examined in isolation. Policymakers, academics, business and patients must be part of the discussion as well as “innovation” because access would not get the focus it needs without it, according to Dorli Kahr-Gottlieb.
Athens’ decision to claim the European Medicine Agency's relocation from London sends a message that medicine is “not just a commodity but a social good”, Greece’s Alternate Minister of Foreign Affairs, Georgios Katrougalos, told EURACTIV.com.